<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="153126">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02023190</url>
  </required_header>
  <id_info>
    <org_study_id>LT01</org_study_id>
    <nct_id>NCT02023190</nct_id>
  </id_info>
  <brief_title>Changes in Body Composition and Nutritional Status in Patients Undergoing Liver Transplantation</brief_title>
  <official_title>Changes in Body Composition and Nutritional Status Assessed by Bioelectrical Impedance Vector Analysis in Cirrhotic Patients Undergoing Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</source>
  <oversight_info>
    <authority>Mexico: Secretaria de Salud</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Liver transplant is the goal treatment for every patient with end-stage chronic liver
      disease.

      Quality of life improves after transplant because the main complications of end-stage liver
      disease disappear, but due to immunosuppression other alterations appear such as metabolic
      alterations, weight gain, among others.

      Body composition and nutritional status can be affected do to post-transplant pharmacologic
      therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Body composition and nutritional status can be affected due to post-transplant pharmacologic
      therapy.

      This is a prospective cohort study, patients from liver transplant waiting list will be
      assessed, pre and post-transplant measures of body composition and nutritional status will
      be obtained.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Body composition</measure>
    <time_frame>Baseline, 7 days, 1 month, 3 months  and 6 months post-tranpslant</time_frame>
    <safety_issue>No</safety_issue>
    <description>Body composition will be assessed through bioelectrical impedance vector analysis graph.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>Baseline, 7 days, 1 month, 3 months  and 6 months post-tranpslant</time_frame>
    <safety_issue>No</safety_issue>
    <description>Nutritional status will be assessed through Phase Angle derived from bioelectrical impedance. Malnutrition is defined as Phase angle &lt; 5.1Â°</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Liver function tests</measure>
    <time_frame>Baseline, 7 days, 1 month, 3 months  and 6 months post-tranpslant</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Nutritional assessment</arm_group_label>
    <description>Nutritional assessment will be performed by bioelectrical impedance vector analysis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be selected from the transplant enrollment list at the Department of
        Gastroenterology in a tertiary care center in Mexico
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Liver cirrhosis (any etiology)

          -  Enrolled in waiting list for tliver transplant

        Exclusion Criteria:

          -  Hepatocellular carcinoma

          -  Chronic renal failure

          -  Congestive cardiac failure

          -  Extremity amputation

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aldo Torre, MD MSci</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aldo Torre, MD MSci</last_name>
    <phone>54870900</phone>
    <phone_ext>2711</phone_ext>
    <email>detoal@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Astrid Ruiz-Margain, B.Sci</last_name>
    <phone>54870900</phone>
    <phone_ext>2711</phone_ext>
    <email>ruizm.astrid@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</name>
      <address>
        <city>Mexico City</city>
        <state>DF</state>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aldo Torre, MD MSci</last_name>
      <phone>54870900</phone>
      <phone_ext>2711</phone_ext>
      <email>detoal@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Astrid Ruiz-Margain, B.Sci</last_name>
      <phone>54870900</phone>
      <phone_ext>2711</phone_ext>
      <email>ruizm.astrid@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Aldo Torre, MD MSci</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Astrid Ruiz-Margain, B.Sci</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ricardo U Macias-Rodriguez, MD MSci</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ignacio Garcia-Juarez, MD MSci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 12, 2014</lastchanged_date>
  <firstreceived_date>December 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</investigator_affiliation>
    <investigator_full_name>ALDO TORRE DELGADILLO</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>liver cirrhosis</keyword>
  <keyword>liver transplant</keyword>
  <keyword>nutritional status</keyword>
  <keyword>bioelectrical impedance vector analysis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
